ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.

Houshi XuAnke ZhangXiaying HanYanning LiZeyu ZhangLiying SongWei WangMeiqing Lou

Published in: Cancer immunology, immunotherapy : CII (2021)

This study demonstrated ITGB2 as a novel predictor for clinical prognosis and response to immunotherapy in gliomas. Assessing expression levels of ITGB2 is a promising method to discover patients that may benefit from immunotherapy.

Keyphrases

end stage renal disease
high grade
newly diagnosed
chronic kidney disease
poor prognosis
peritoneal dialysis
prognostic factors
long non coding rna